109149 ⎘
Structure or type of the nucleic acid; Type of nucleic acid; Nucleic acids forming more than 2 strands, e.g. TFOs on a single-stranded target, e.g. fold-back TFOs
GENOME EDITING USING EFFECTOR OLIGONUCLEOTIDES FOR THERAPEUTIC TREATMENT
#2METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#3COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS
#4COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE
#5METHOD FOR SUPPRESSING PROTEIN TRANSLATION REACTION USING STAPLE NUCLEIC ACID
#6Genome editing using effector oligonucleotides for therapeutic treatment
#7COMPOSITIONS AND METHODS FOR ENHANCING HOMOLOGOUS RECOMBINATION
#8Methods and compositions for modulating gene expression
#9Hybrid oligonucleotides and uses thereof
#10Compositions and methods for enhancing homologous recombination
#11Neutral nucleic acid ligands
#12Compositions for enhancing targeted gene editing and methods of use thereof
#13Genome editing using effector oligonucleotides for therapeutic treatment
#14COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOF
#15COMPOSITIONS AND METHODS FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS
#16Compositions and methods for inhibiting expression of anti-apoptotic genes
#17COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOF
#18Cleavage kit, and gene therapy by using the same and nucleic acid cleavage detection apparatus
#19COMPOSITIONS AND METHODS FOR REGULATING GENE TRANSCRIPTION
#20Nucleic acid agents for downregulating H19, and methods of using same
#21Nucleic acid agents for downregulating H19 and methods of using same
#22Compositions and methods for inhibiting expression of anti-apoptotic genes
#23Modified triple-helix forming oligonucleotides for targeted mutagenesis
#24Compositions and methods for inhibiting expression of anti-apoptotic genes
#25Antisense and antigene therapeutics with improved binding properties and methods for their use
#26Methods and compositions for blocking progression of a disease state
#27Compositions and methods for inhibiting expression of anti-apoptotic genes
#28Oligonucleotide complexes for use as anti-viral therapeutics
#29Treatment of Parkinson's disease with oligonucleotides
#30Triplex-forming oligonucleotides containing modified purines and their applications